Hideki Fujimori
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 4
- Nephrology top 5%
- Neurology top 10%
- Ophthalmology top 5%
-
- Lung Cancer Diagnosis and Treatment 6
- Tracheal and airway disorders 5
-
- Cancer Diagnosis and Treatment 3
-
- Vascular Anomalies and Treatments 3
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Gastrointestinal disorders and treatments 2
- Congenital Diaphragmatic Hernia Studies 2
- Co-authors
- Sho‐ichi YamagishiHideto YonekuraHiroshi YamamotoYasuhiko YamamotoNobushige TanakaYasuki YamamotoNobukazu TanakaHareaki Yamamoto
- Partner nations
- JapanNetherlandsGreece
In The Last Decade
Hideki Fujimori
22 papers receiving 857 citations
Peers
Comparison fields: 5 of 84
- Clinical Biochemistry 463
- Nephrology 114
- Endocrinology, Diabetes and Metabolism 213
- Neurology 94
- Ophthalmology 66
Countries citing papers authored by Hideki Fujimori
This map shows the geographic impact of Hideki Fujimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Fujimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Fujimori more than expected).
Fields of papers citing papers by Hideki Fujimori
This network shows the impact of papers produced by Hideki Fujimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Fujimori. The network helps show where Hideki Fujimori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hideki Fujimori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Surgical Treatment to Bilateral Multiple Primary Lung Cancer Patients]. | 2021 | 1 |
| 2 | 2020 | 6 | |
| 3 | 2017 | 2 | |
| 4 | [Extended Right Pneumonectomy with Partial Resection of the Left Atrium without Cardiopulmonary Bypass]. | 2016 | 1 |
| 5 | 2015 | 3 | |
| 6 | 2012 | 2 | |
| 7 | 2010 | 26 | |
| 8 | [Lung adenocarcinoma originated from bulla wall accompanying spontaneous hemopneumothorax; report of a case]. | 2010 | 2 |
| 9 | 2009 | 1 | |
| 10 | 2009 | 6 | |
| 11 | 2008 | 1 | |
| 12 | 2005 | 10 | |
| 13 | 2005 | 0 | |
| 14 | 2000 | 367 | |
| 15 | 1999 | 49 | |
| 16 | 1999 | 94 | |
| 17 | Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. | 1999 | 114 |
| 18 | 1998 | 164 | |
| 19 | 1998 | 13 | |
| 20 | 1998 | 2 |
About Hideki Fujimori
Hideki Fujimori is a scholar working on Microbiology, Clinical Biochemistry and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 873 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Tracheal and airway disorders (5 papers), Advanced Glycation End Products research (4 papers), Cancer Diagnosis and Treatment (3 papers), Vascular Anomalies and Treatments (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Gastrointestinal disorders and treatments (2 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (463 citations), Nephrology (114 citations) and Endocrinology, Diabetes and Metabolism (213 citations). Hideki Fujimori has collaborated with scholars based in Japan, Netherlands and Greece. Frequent co-authors include Sho‐ichi Yamagishi, Hideto Yonekura, Hiroshi Yamamoto, Yasuhiko Yamamoto, Nobushige Tanaka, Yasuki Yamamoto, Nobukazu Tanaka, Hareaki Yamamoto, Hiroshi Urayama and Yoh Watanabe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.